Evolus GAAP EPS of $0.00 beats by $0.05, revenue of $89.2M misses by $0.38M
Source: SeekingAlpha
2026-03-03 16:17:18 ET
More on Evolus
- Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026
- Evolus sees Q4 net revenue between $88.6M and $90.6M
- Seeking Alpha’s Quant Rating on Evolus
- Historical earnings data for Evolus
- Financial information for Evolus
Read the full article on Seeking Alpha
For further details see:
Evolus GAAP EPS of $0.00 beats by $0.05, revenue of $89.2M misses by $0.38M
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
2.85% G/L:
$5.37 Last:
398,630 Volume:
$5.54 Open:
EOLS Latest News
EOLS Stock Data
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
